Abreva works by stopping the cold sore virus from fusing with healthy skin cells. Unlike prescription antivirals that interfere with viral replication after a cell is already infected, Abreva’s active ingredient (docosanol 10%) blocks the virus at the cell’s outer membrane, preventing it from getting inside in the first place. This unique mechanism makes it the only FDA-approved over-the-counter antiviral for cold sores, first cleared for sale in 2000.
How It Blocks the Virus
Cold sores are caused by herpes simplex virus type 1 (HSV-1), which spreads by attaching to healthy skin cells and fusing with their outer membranes. Once inside, the virus hijacks the cell’s machinery to make copies of itself, and the cycle spreads outward, creating the familiar blister.
Docosanol is a fatty alcohol that gets absorbed into the membranes of your skin cells. Once incorporated, it changes the membrane’s properties in a way that prevents HSV-1 from latching on and fusing. Think of it as reinforcing a door so the virus can’t push through. The virus particles are still present on the skin’s surface, but they can’t enter new cells, which limits the outbreak’s size and helps it resolve faster.
This is fundamentally different from how prescription antivirals work. Prescription options target the virus’s ability to copy its DNA once it’s already inside a cell. Docosanol works a step earlier, at the point of entry. Because it acts on the human cell membrane rather than on the virus directly, there’s no known mechanism for the virus to develop resistance to it.
How Much It Actually Helps
In the largest clinical trial, 370 people treated with docosanol cream healed in a median of 4.1 days, which was about 18 hours faster than the placebo group of 367 people. That difference was statistically significant, but it’s worth setting expectations: you’re looking at roughly three-quarters of a day shaved off your cold sore, not a dramatic overnight cure.
It’s also worth noting that in an animal study comparing several topical treatments, docosanol cream did not show a statistically significant difference from a vehicle control (a cream without active ingredient). In that same model, prescription topical antivirals performed better. The human trial data tells a more favorable story, but Abreva is generally considered less potent than prescription options. For people who get frequent or severe outbreaks, a prescription antiviral is likely a better fit.
Why Timing Matters So Much
Because docosanol works by protecting uninfected cells, it’s most useful when there are still plenty of healthy cells left to protect. That means the earlier you apply it, the better. The ideal window is during the prodrome stage, that first tingle, itch, or burning sensation you feel before any visible sore appears. At that point, the virus is just beginning to spread from cell to cell, and blocking further entry can meaningfully limit the outbreak.
Once a full blister has formed, most of the local damage is already done. Applying Abreva at that stage may still offer some benefit, but the window for its mechanism to make the biggest difference has narrowed considerably. If you’re prone to cold sores, keeping a tube accessible so you can apply it at the first sign of tingling gives you the best shot at a shorter, smaller outbreak.
How to Apply It
The recommended application is five times a day, spread evenly throughout your waking hours, until the sore has fully healed. You apply a thin layer directly to the affected area and the skin immediately around it. Clean hands before and after application help prevent spreading the virus to other parts of your face or to other people.
Most cold sores heal within 7 to 10 days regardless of treatment. If your sore hasn’t improved after 10 days of using Abreva, that’s a signal to check in with a healthcare provider, as it could indicate something other than a typical HSV-1 outbreak.
What It Treats (and Doesn’t)
Abreva is indicated only for cold sores on or around the lips, which are almost always caused by HSV-1. About 40% of the U.S. population deals with recurrent cold sores. While HSV-1 can also cause genital herpes (it’s now responsible for over 70% of new genital herpes diagnoses in young people), Abreva is not approved or recommended for genital outbreaks. It also won’t help with canker sores, which are a completely different condition unrelated to herpes.
Side Effects
Docosanol cream is well tolerated. The most commonly reported reactions in clinical trials were mild and localized: slight skin irritation, dryness, or rash at the application site. These tend to be minor enough that most people continue using it without issue. Because the drug acts on your own cell membranes rather than being absorbed systemically, it doesn’t carry the kinds of internal side effects associated with oral antiviral medications.